Pfizer with a potential new Weight Loss Drug
Written by JDPGlobal | Monday, 27 June 2005
Pfizer, the world's biggest drug maker with 2004 sales of $52.5 billion has hit the market with a new formula that combines its best-selling cholesterol drug Lipitor that lowers levels of bad cholesterol, with its experimental compound torcetrapib, which is designed to raise levels of HDL, or good cholesterol. This provides even more protection from heart attacks and stroke.
The combination drug, produced at an expanded plant in Loughbeg, Ireland, has the potential to outstrip Lipitor's current $10 billion in annual sales.
